Annual CAPEX
$1.82 M
-$10.00 K-0.55%
31 December 2023
Summary:
Celldex Therapeutics annual capital expenditures is currently $1.82 million, with the most recent change of -$10.00 thousand (-0.55%) on 31 December 2023. During the last 3 years, it has risen by +$266.00 thousand (+17.14%). CLDX annual CAPEX is now -62.72% below its all-time high of $4.88 million, reached on 31 December 2015.CLDX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$545.00 K
+$271.00 K+98.91%
01 September 2024
Summary:
Celldex Therapeutics quarterly capital expenditures is currently $545.00 thousand, with the most recent change of +$271.00 thousand (+98.91%) on 01 September 2024. Over the past year, it has increased by +$388.00 thousand (+247.13%). CLDX quarterly CAPEX is now -83.78% below its all-time high of $3.36 million, reached on 30 June 2007.CLDX Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.83 M
+$388.00 K+26.93%
01 September 2024
Summary:
Celldex Therapeutics TTM capital expenditures is currently $1.83 million, with the most recent change of +$388.00 thousand (+26.93%) on 01 September 2024. Over the past year, it has increased by +$442.00 thousand (+31.87%). CLDX TTM CAPEX is now -62.49% below its all-time high of $4.88 million, reached on 31 December 2015.CLDX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -0.6% | +247.1% | +31.9% |
3 y3 years | +17.1% | +194.6% | +60.2% |
5 y5 years | +123.6% | +283.8% | +132.1% |
CLDX CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -0.6% | +45.6% | -19.0% | +247.1% | -6.1% | +60.2% |
5 y | 5 years | -0.6% | +148.7% | -40.1% | +419.1% | -6.1% | +150.2% |
alltime | all time | -62.7% | +2314.3% | -83.8% | +116.3% | -62.5% | +161.0% |
Celldex Therapeutics CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $545.00 K(+98.9%) | $1.83 M(+26.9%) |
June 2024 | - | $274.00 K(-20.3%) | $1.44 M(-8.6%) |
Mar 2024 | - | $344.00 K(-48.3%) | $1.58 M(-13.3%) |
Dec 2023 | $1.82 M(-0.5%) | $666.00 K(+324.2%) | $1.82 M(+31.1%) |
Sept 2023 | - | $157.00 K(-61.7%) | $1.39 M(-11.9%) |
June 2023 | - | $410.00 K(-29.9%) | $1.57 M(-14.3%) |
Mar 2023 | - | $585.00 K(+148.9%) | $1.84 M(+0.5%) |
Dec 2022 | $1.83 M(+46.4%) | $235.00 K(-31.9%) | $1.83 M(-6.1%) |
Sept 2022 | - | $345.00 K(-48.7%) | $1.95 M(+9.0%) |
June 2022 | - | $673.00 K(+17.0%) | $1.79 M(+42.2%) |
Mar 2022 | - | $575.00 K(+62.4%) | $1.26 M(+0.6%) |
Dec 2021 | $1.25 M(-19.5%) | $354.00 K(+91.4%) | $1.25 M(+9.4%) |
Sept 2021 | - | $185.00 K(+29.4%) | $1.14 M(+2.2%) |
June 2021 | - | $143.00 K(-74.8%) | $1.12 M(-40.7%) |
Mar 2021 | - | $567.00 K(+129.6%) | $1.88 M(+21.4%) |
Dec 2020 | $1.55 M(+112.3%) | $247.00 K(+54.4%) | $1.55 M(+10.1%) |
Sept 2020 | - | $160.00 K(-82.4%) | $1.41 M(+1.3%) |
June 2020 | - | $910.00 K(+287.2%) | $1.39 M(+78.5%) |
Mar 2020 | - | $235.00 K(+123.8%) | $780.00 K(+6.7%) |
Dec 2019 | $731.00 K(-10.1%) | $105.00 K(-26.1%) | $731.00 K(-7.2%) |
Sept 2019 | - | $142.00 K(-52.3%) | $788.00 K(+11.6%) |
June 2019 | - | $298.00 K(+60.2%) | $706.00 K(-4.6%) |
Mar 2019 | - | $186.00 K(+14.8%) | $740.00 K(-9.0%) |
Dec 2018 | $813.00 K(-54.5%) | $162.00 K(+170.0%) | $813.00 K(-3.3%) |
Sept 2018 | - | $60.00 K(-81.9%) | $841.00 K(-20.9%) |
June 2018 | - | $332.00 K(+28.2%) | $1.06 M(-36.5%) |
Mar 2018 | - | $259.00 K(+36.3%) | $1.67 M(-6.4%) |
Dec 2017 | $1.79 M(-35.0%) | $190.00 K(-32.6%) | $1.79 M(-20.0%) |
Sept 2017 | - | $282.00 K(-70.1%) | $2.24 M(-19.0%) |
June 2017 | - | $942.00 K(+151.9%) | $2.76 M(+6.8%) |
Mar 2017 | - | $374.00 K(-41.4%) | $2.58 M(-6.0%) |
Dec 2016 | $2.75 M(-43.6%) | $638.00 K(-20.8%) | $2.75 M(+9.2%) |
Sept 2016 | - | $806.00 K(+5.1%) | $2.52 M(-18.0%) |
June 2016 | - | $767.00 K(+42.0%) | $3.08 M(-20.2%) |
Mar 2016 | - | $540.00 K(+32.7%) | $3.85 M(-20.9%) |
Dec 2015 | $4.88 M(+152.8%) | $407.00 K(-70.1%) | $4.88 M(+5.3%) |
Sept 2015 | - | $1.36 M(-12.0%) | $4.63 M(+17.5%) |
June 2015 | - | $1.55 M(-0.9%) | $3.94 M(+19.7%) |
Mar 2015 | - | $1.56 M(+857.7%) | $3.29 M(+70.8%) |
Dec 2014 | $1.93 M(-54.3%) | $163.00 K(-75.7%) | $1.93 M(-52.8%) |
Sept 2014 | - | $672.00 K(-25.3%) | $4.08 M(-7.1%) |
June 2014 | - | $899.00 K(+361.0%) | $4.40 M(+3.4%) |
Mar 2014 | - | $195.00 K(-91.6%) | $4.25 M(+0.8%) |
Dec 2013 | $4.22 M(+1292.4%) | $2.32 M(+135.6%) | $4.22 M(+109.8%) |
Sept 2013 | - | $984.00 K(+30.3%) | $2.01 M(+83.2%) |
June 2013 | - | $755.00 K(+366.0%) | $1.10 M(+159.6%) |
Mar 2013 | - | $162.00 K(+47.3%) | $423.00 K(+39.6%) |
Dec 2012 | $303.00 K(-40.5%) | $110.00 K(+54.9%) | $303.00 K(+1.3%) |
Sept 2012 | - | $71.00 K(-11.3%) | $299.00 K(-14.3%) |
June 2012 | - | $80.00 K(+90.5%) | $349.00 K(0.0%) |
Mar 2012 | - | $42.00 K(-60.4%) | $349.00 K(-31.4%) |
Dec 2011 | $509.00 K(-75.8%) | $106.00 K(-12.4%) | $509.00 K(-39.5%) |
Sept 2011 | - | $121.00 K(+51.2%) | $841.00 K(-32.9%) |
June 2011 | - | $80.00 K(-60.4%) | $1.25 M(-34.7%) |
Mar 2011 | - | $202.00 K(-53.9%) | $1.92 M(-8.7%) |
Dec 2010 | $2.10 M(+297.7%) | $438.00 K(-17.8%) | $2.10 M(+20.0%) |
Sept 2010 | - | $533.00 K(-28.5%) | $1.75 M(+31.4%) |
June 2010 | - | $745.00 K(+94.0%) | $1.33 M(+72.5%) |
Mar 2010 | - | $384.00 K(+336.4%) | $772.00 K(+46.2%) |
Dec 2009 | $528.00 K(-59.5%) | $88.00 K(-23.5%) | $528.00 K(+13.1%) |
Sept 2009 | - | $115.00 K(-37.8%) | $467.00 K(-62.1%) |
June 2009 | - | $185.00 K(+32.1%) | $1.23 M(-13.9%) |
Mar 2009 | - | $140.00 K(+418.5%) | $1.43 M(+9.8%) |
Dec 2008 | $1.30 M(+1633.1%) | $27.00 K(-96.9%) | $1.30 M(+1.9%) |
Sept 2008 | - | $881.00 K(+129.1%) | $1.28 M(-143.5%) |
June 2008 | - | $384.50 K(+2976.0%) | -$2.94 M(<-9900.0%) |
Mar 2008 | - | $12.50 K(+420.8%) | $29.90 K(-60.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2007 | $75.30 K(-97.0%) | $2400.00(-100.1%) | $75.40 K(-102.5%) |
Sept 2007 | - | -$3.34 M(-199.6%) | -$3.00 M(-193.0%) |
June 2007 | - | $3.36 M(+5691.6%) | $3.22 M(+74.0%) |
Mar 2007 | - | $58.00 K(-101.9%) | $1.85 M(-25.3%) |
Dec 2006 | $2.48 M(+336.6%) | -$3.07 M(-206.7%) | $2.48 M(-41.0%) |
Sept 2006 | - | $2.88 M(+44.7%) | $4.20 M(+125.8%) |
June 2006 | - | $1.99 M(+190.5%) | $1.86 M(+472.7%) |
Mar 2006 | - | $684.40 K(-150.7%) | $324.70 K(>+9900.0%) |
Dec 2005 | - | -$1.35 M(-351.0%) | $0.00(-100.0%) |
Sept 2005 | - | $538.30 K(+18.8%) | -$206.60 K(-150.2%) |
June 2005 | - | $453.20 K(+26.0%) | $411.90 K(+256.9%) |
Mar 2005 | - | $359.70 K(-123.1%) | $115.40 K(>+9900.0%) |
Dec 2004 | - | -$1.56 M(-234.7%) | $0.00(-100.0%) |
Sept 2004 | - | $1.16 M(+638.2%) | $1.39 M(+471.8%) |
June 2004 | - | $156.70 K(-35.9%) | $243.10 K(+68.9%) |
Mar 2004 | - | $244.30 K(-245.6%) | $143.90 K(>+9900.0%) |
Dec 2003 | - | -$167.80 K(-1794.9%) | $0.00(-100.0%) |
Sept 2003 | - | $9900.00(-82.8%) | $343.50 K(-10.6%) |
June 2003 | - | $57.50 K(-42.7%) | $384.30 K(-20.4%) |
Mar 2003 | - | $100.40 K(-42.9%) | $482.90 K(-14.9%) |
Dec 2002 | $567.70 K(-6.2%) | $175.70 K(+246.5%) | $567.70 K(+5.0%) |
Sept 2002 | - | $50.70 K(-67.5%) | $540.90 K(-42.9%) |
June 2002 | - | $156.10 K(-15.7%) | $946.50 K(+30.8%) |
Mar 2002 | - | $185.20 K(+24.4%) | $723.50 K(+19.5%) |
Dec 2001 | $605.20 K(+241.5%) | $148.90 K(-67.4%) | $605.20 K(+19.1%) |
Sept 2001 | - | $456.30 K(-782.1%) | $508.20 K(+468.5%) |
June 2001 | - | -$66.90 K(-200.0%) | $89.40 K(-54.9%) |
Mar 2001 | - | $66.90 K(+28.9%) | $198.40 K(+12.0%) |
Dec 2000 | $177.20 K(-74.3%) | $51.90 K(+38.4%) | $177.20 K(-17.1%) |
Sept 2000 | - | $37.50 K(-10.9%) | $213.80 K(+21.3%) |
June 2000 | - | $42.10 K(-7.9%) | $176.30 K(-24.7%) |
Mar 2000 | - | $45.70 K(-48.4%) | $234.20 K(-66.0%) |
Dec 1999 | $688.50 K(+129.5%) | $88.50 K(>+9900.0%) | $688.50 K(-13.9%) |
Sept 1999 | - | $0.00(-100.0%) | $800.00 K(0.0%) |
June 1999 | - | $100.00 K(-80.0%) | $800.00 K(0.0%) |
Mar 1999 | - | $500.00 K(+150.0%) | $800.00 K(+166.7%) |
Dec 1998 | $300.00 K(+200.0%) | $200.00 K(>+9900.0%) | $300.00 K(+200.0%) |
Sept 1998 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
June 1998 | - | $100.00 K(>+9900.0%) | $100.00 K(0.0%) |
Dec 1997 | $100.00 K(-83.3%) | $0.00(0.0%) | $100.00 K(-85.7%) |
Sept 1997 | - | $0.00(-100.0%) | $700.00 K(+75.0%) |
June 1997 | - | $100.00 K(-83.3%) | $400.00 K(-33.3%) |
Dec 1996 | $600.00 K(0.0%) | $600.00 K(-300.0%) | $600.00 K(-700.0%) |
Sept 1996 | - | -$300.00 K(-57.1%) | -$100.00 K(-111.1%) |
June 1996 | - | -$700.00 K(-170.0%) | $900.00 K(-43.8%) |
Mar 1996 | - | $1.00 M(-1100.0%) | $1.60 M(+166.7%) |
Dec 1995 | $600.00 K(-25.0%) | -$100.00 K(-114.3%) | $600.00 K(-14.3%) |
Sept 1995 | - | $700.00 K(>+9900.0%) | $700.00 K(-12.5%) |
Dec 1994 | $800.00 K(+60.0%) | $0.00(-100.0%) | $800.00 K(0.0%) |
Sept 1994 | - | $100.00 K(-80.0%) | $800.00 K(-11.1%) |
June 1994 | - | $500.00 K(+150.0%) | $900.00 K(+80.0%) |
Mar 1994 | - | $200.00 K(>+9900.0%) | $500.00 K(0.0%) |
Dec 1993 | $500.00 K(0.0%) | $0.00(-100.0%) | $500.00 K(0.0%) |
Sept 1993 | - | $200.00 K(+100.0%) | $500.00 K(+25.0%) |
June 1993 | - | $100.00 K(-50.0%) | $400.00 K(-33.3%) |
Mar 1993 | - | $200.00 K(+100.0%) | $600.00 K(-14.3%) |
Dec 1992 | $500.00 K(+25.0%) | - | - |
Oct 1992 | - | $100.00 K(-66.7%) | $700.00 K(0.0%) |
July 1992 | - | $300.00 K(+50.0%) | $700.00 K(+75.0%) |
Apr 1992 | - | $200.00 K(+100.0%) | $400.00 K(+33.3%) |
Apr 1992 | $400.00 K(0.0%) | - | - |
Jan 1992 | - | $100.00 K(0.0%) | $300.00 K(-25.0%) |
Oct 1991 | - | $100.00 K(0.0%) | $400.00 K(0.0%) |
Apr 1991 | $400.00 K(-42.9%) | $100.00 K(-50.0%) | $400.00 K(+33.3%) |
Jan 1991 | - | $200.00 K(>+9900.0%) | $300.00 K(+200.0%) |
Oct 1990 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
July 1990 | - | $100.00 K | $100.00 K |
Apr 1990 | $700.00 K | - | - |
FAQ
- What is Celldex Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics annual CAPEX year-on-year change?
- What is Celldex Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly CAPEX year-on-year change?
- What is Celldex Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics TTM CAPEX year-on-year change?
What is Celldex Therapeutics annual capital expenditures?
The current annual CAPEX of CLDX is $1.82 M
What is the all time high annual CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high annual capital expenditures is $4.88 M
What is Celldex Therapeutics annual CAPEX year-on-year change?
Over the past year, CLDX annual capital expenditures has changed by -$10.00 K (-0.55%)
What is Celldex Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of CLDX is $545.00 K
What is the all time high quarterly CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly capital expenditures is $3.36 M
What is Celldex Therapeutics quarterly CAPEX year-on-year change?
Over the past year, CLDX quarterly capital expenditures has changed by +$388.00 K (+247.13%)
What is Celldex Therapeutics TTM capital expenditures?
The current TTM CAPEX of CLDX is $1.83 M
What is the all time high TTM CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM capital expenditures is $4.88 M
What is Celldex Therapeutics TTM CAPEX year-on-year change?
Over the past year, CLDX TTM capital expenditures has changed by +$442.00 K (+31.87%)